- Home
- CCBG vs STOK Comparison
CCBG vs STOK Comparison
Compare CCBG & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- STOK
- Stock Information
- Founded
- CCBG 1895
- STOK 2014
- Country
- CCBG United States
- STOK United States
- Employees
- CCBG N/A
- STOK N/A
- Industry
- CCBG Major Banks
- STOK Biotechnology: Pharmaceutical Preparations
- Sector
- CCBG Finance
- STOK Health Care
- Exchange
- CCBG Nasdaq
- STOK Nasdaq
- Market Cap
- CCBG 701.6M
- STOK 740.9M
- IPO Year
- CCBG N/A
- STOK 2019
- Fundamental
- Price
- CCBG $40.42
- STOK $13.10
- Analyst Decision
- CCBG Buy
- STOK Strong Buy
- Analyst Count
- CCBG 2
- STOK 5
- Target Price
- CCBG $39.50
- STOK $27.75
- AVG Volume (30 Days)
- CCBG 44.2K
- STOK 794.4K
- Earning Date
- CCBG 07-22-2025
- STOK 08-06-2025
- Dividend Yield
- CCBG 2.38%
- STOK N/A
- EPS Growth
- CCBG 14.00
- STOK N/A
- EPS
- CCBG 3.42
- STOK 0.88
- Revenue
- CCBG $240,944,000.00
- STOK $190,908,000.00
- Revenue This Year
- CCBG $10.45
- STOK $378.84
- Revenue Next Year
- CCBG $3.50
- STOK N/A
- P/E Ratio
- CCBG $11.82
- STOK $14.94
- Revenue Growth
- CCBG 8.96
- STOK 2333.81
- 52 Week Low
- CCBG $30.99
- STOK $5.35
- 52 Week High
- CCBG $42.33
- STOK $16.15
- Technical
- Relative Strength Index (RSI)
- CCBG 51.16
- STOK 58.53
- Support Level
- CCBG $40.40
- STOK $12.26
- Resistance Level
- CCBG $42.33
- STOK $14.99
- Average True Range (ATR)
- CCBG 0.89
- STOK 0.84
- MACD
- CCBG -0.16
- STOK 0.10
- Stochastic Oscillator
- CCBG 13.57
- STOK 43.21
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About STOK Stoke Therapeutics Inc.
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.